Quan Jiang

发表

Identification of CYP 2A6 inhibitors in an effort to mitigate the harmful effects of the phytochemical nicotine

J. Sridhar, M. Foroozesh, M. Bratton, 2021, Journal of cancer metastasis and treatment.

Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer.

Shilong Zheng, Guangdi Wang, Quan Jiang, 2013, Future medicinal chemistry.

Discovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion.

M. Burow, Madhusoodanan Mottamal, Shilong Zheng, 2013, ACS medicinal chemistry letters.

Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer.

Shilong Zheng, Guangdi Wang, Quan Jiang, 2012, ACS medicinal chemistry letters.

Ortho-Methylarylamines as Time-Dependent Inhibitors of Cytochrome P450 1A1 Enzyme.

Kevin E. Riley, J. Sridhar, Jiawang Liu, 2017, Drug metabolism letters.

Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.

Ming Zhao, J. Sridhar, Jiawang Liu, 2013, Journal of medicinal chemistry.

Design, synthesis, and osteogenic activity of daidzein analogs on human mesenchymal stem cells.

S. Elliott, M. Burow, S. Boue, 2014, ACS medicinal chemistry letters.

Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells.

J. Sridhar, D. Bhatnagar, J. McLachlan, 2010, Journal of medicinal chemistry.

Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms

J. Gimble, Jason F. Ohlstein, S. Elliott, 2014, Stem Cell Research & Therapy.